IGF-IR plays a multifunctional role in human CRC growth and is widely regarded as an attractive target for anticancer drug treatment based on the observation that inhibition of IGF-1R function results in apoptosis and inhibition of tumor growth. This evidence concerns the gene IGF1R and colorectal carcinoma.